Sanofi SA (EPA: SAN) is in focus today after teaming up with OpenAI to deploy artificial intelligence for drug development. Working with the AI company will help Sanofi “go to market faster with ...

Tuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug development projects. Also Read: Drugmaker Sanofi’s Strong Dupixent ...

In 2024, OpenAI announced a multiyear partnership with News Corp: which is currently controlled by the Murdoch family. Through this agreement OpenAI will gain access to both current and archival ...